FDA Warning Letter — Devalingam Mahalingam, M.D., Ph.D.
The FDA took a Warning Letter action against Devalingam Mahalingam, M.D., Ph.D. on December 11, 2025 (Chicago, IL). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Devalingam Mahalingam, M.D., Ph.D.
- Date
- December 11, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Chicago, IL (United States)